308 related articles for article (PubMed ID: 2016246)
1. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
[TBL] [Abstract][Full Text] [Related]
2. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
[TBL] [Abstract][Full Text] [Related]
3. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
Hantouche EG; Bouhassira M; Lancrenon S
Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
[TBL] [Abstract][Full Text] [Related]
4. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
6. Obsessive-compulsive disorder.
Insel TR
Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of obsessive-compulsive disorders.
Murray JB
Genet Soc Gen Psychol Monogr; 1986 May; 112(2):173-99. PubMed ID: 2875011
[TBL] [Abstract][Full Text] [Related]
8. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
Pato MT; Hill JL; Murphy DL
Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458
[TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
[TBL] [Abstract][Full Text] [Related]
10. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
DeVeaugh-Geiss J; Moroz G; Biederman J; Cantwell D; Fontaine R; Greist JH; Reichler R; Katz R; Landau P
J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):45-9. PubMed ID: 1537780
[TBL] [Abstract][Full Text] [Related]
11. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
12. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
Zohar J; Kaplan Z; Benjamin J
J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
[TBL] [Abstract][Full Text] [Related]
13. [Biological treatments in obsessive-compulsive disorder].
Montgomery SA; Fineberg NA; Montgomery D
Encephale; 1990; 16 Spec No():335-9. PubMed ID: 2209492
[TBL] [Abstract][Full Text] [Related]
14. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
Hewlett WA; Vinogradov S; Agras WS
J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
[TBL] [Abstract][Full Text] [Related]
15. An integrated approach to treatment of obsessive compulsive disorder.
Greist JH
J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
[TBL] [Abstract][Full Text] [Related]
16. Predictors of drug treatment response in obsessive-compulsive disorder.
Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
DeVeaugh-Geiss J; Katz R; Landau P; Goodman W; Rasmussen S
Psychopharmacol Bull; 1990; 26(1):54-9. PubMed ID: 2196627
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of obsessive-compulsive disorder.
Klein DF
Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491
[TBL] [Abstract][Full Text] [Related]
19. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
Mavissakalian MR; Jones B; Olson S; Perel JM
J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
[TBL] [Abstract][Full Text] [Related]
20. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.
Pigott TA; Pato MT; L'Heureux F; Hill JL; Grover GN; Bernstein SE; Murphy DL
J Clin Psychopharmacol; 1991 Aug; 11(4):242-8. PubMed ID: 1918422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
